.

Make Better Decisions

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Cipla
Baxter
Daiichi Sankyo
McKesson
Colorcon
UBS
Fuji
Chinese Patent Office
Dow
Cerilliant

Generated: September 22, 2017

DrugPatentWatch Database Preview

FOUGERA PHARMS Company Profile

« Back to Dashboard

What is the competitive landscape for FOUGERA PHARMS, and when can generic versions of FOUGERA PHARMS drugs launch?

FOUGERA PHARMS has one hundred and eleven approved drugs.

There is one US patent protecting FOUGERA PHARMS drugs.

There are seventeen patent family members on FOUGERA PHARMS drugs in fifteen countries.

Summary for Applicant: FOUGERA PHARMS

Patents:1
Tradenames:53
Ingredients:45
NDAs:111
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Fougera Pharms
CLINDAMYCIN PHOSPHATE
clindamycin phosphate
SOLUTION;TOPICAL065254-001Feb 14, 2006ATRXNoNo► Subscribe► Subscribe► Subscribe
Fougera Pharms
NYSTATIN
nystatin
OINTMENT;TOPICAL062124-002Sep 23, 1982ATRXNoYes► Subscribe► Subscribe► Subscribe
Fougera Pharms
CARMOL HC
hydrocortisone acetate; urea
CREAM;TOPICAL080505-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Fougera Pharms Inc
FLUOCINONIDE
fluocinonide
CREAM;TOPICAL073030-001Oct 17, 1994AB1RXNoNo► Subscribe► Subscribe► Subscribe
Fougera Pharms
PREDNICARBATE
prednicarbate
OINTMENT;TOPICAL077236-001Mar 9, 2007ABRXNoNo► Subscribe► Subscribe► Subscribe
Fougera Pharms Inc
FLUOCINOLONE ACETONIDE
fluocinolone acetonide
CREAM;TOPICAL088169-001Dec 16, 1982ATRXNoNo► Subscribe► Subscribe► Subscribe
Fougera Pharms
CUTIVATE
fluticasone propionate
LOTION;TOPICAL021152-001Mar 31, 2005ABRXYesYes► Subscribe► Subscribe► Subscribe
Fougera Pharms Inc
FLUOCINOLONE ACETONIDE
fluocinolone acetonide
OINTMENT;TOPICAL088168-001Dec 16, 1982ATRXNoNo► Subscribe► Subscribe► Subscribe
Fougera Pharms
ALCLOMETASONE DIPROPIONATE
alclometasone dipropionate
CREAM;TOPICAL076973-001Jul 12, 2005ABRXNoYes► Subscribe► Subscribe► Subscribe
Fougera Pharms Inc
GENTAMICIN SULFATE
gentamicin sulfate
OINTMENT;TOPICAL062533-001Oct 5, 1984ATRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Fougera Pharms

Paragraph IV activity for FOUGERA PHARMS drugs

Drugname Dosage Strength Tradename Submissiondate
diclofenac sodium
Topical Gel3%
SOLARAZE
12/16/2009
fluticasone propionate
Lotion0.05%
CUTIVATE
7/28/2008

International Patent Family for Fougera Pharms Drugs

Country Document Number Estimated Expiration
Israel142471► Subscribe
Australia754480► Subscribe
Poland348029► Subscribe
Brazil9914703► Subscribe
Hungary0104251► Subscribe
China1176659► Subscribe
Norway20011911► Subscribe
European Patent Office1123101► Subscribe
United Kingdom9823036► Subscribe
Turkey200101109► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Supplementary Protection Certificates for Fougera Pharms Drugs

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
269Luxembourg► SubscribePRODUCT NAME: AZELASTINE,OU UN SEL PHARMACEUTIQUEMENT ACCEPTABLE DE CELUICI,ET UN ESTER PHARMACEUTIQUEMENT ACCEPTABLE DE FLUTICASONE
2013025,C1304992Lithuania► SubscribePRODUCT NAME: CLINDAMYCINUM + TRETINOINUM; REGISTRATION NO/DATE: LT/1/13/3279/001, 2013 04 26 LT/1/13/3279/002, 2013 04 26 PA1332/043/001 20130323
C/GB02/033United Kingdom► SubscribePRODUCT NAME: FORMOTEROL (OPTIONALLY IN THE FORM OF THE FREE BASE OR A PHYSIOLOGICALLY ACCEPTABLE SALT THEREOF, OR A SOLVATE OF SUCH FREE BASE OR SALT ESPECIALLY AS FORMOTEROL FUMARATE DIHYDRATE) AND BUDESONIDE; REGISTERED: SE SE16047, 16048 20000825; UK PL17901/0091 20010515; UK PL17901/0092 20010515
2013 00053Denmark► SubscribePRODUCT NAME: CLINDAMYCIN (SOM CLINDAMYCIN PHOSPHATE) OG TRETINOIN; NAT. REG. NO/DATE: 48954 20130416; FIRST REG. NO/DATE: IE PA1332/043/001 20130322
C0021Belgium► SubscribePRODUCT NAME: LANSOPRAZOLE + CLARITHROMYCINE + METRONIDAZOLE; REGISTRATION NO/DATE IN FRANCE: K 27 17033R DU 19960209; REGISTRATION NO/DATE AT EEC: K 27 17033R DU 19960209
C/GB10/005United Kingdom► SubscribePRODUCT NAME: ADAPALENE AND BENZOYL PEROXIDE; REGISTERED: DK 40440 20071218; UK PL10590/0057 20091111
C/GB99/003United Kingdom► SubscribePRODUCT NAME: IMIQUIMOD; REGISTERED: UK EU/1/98/080/001 19980918
C/GB10/012United Kingdom► SubscribePRODUCT NAME: A COMBINATION OF ACYCLOVIR AND HYDROCORTISONE; REGISTERED: UK PL18191/0001-0001 20091112
C0038France► SubscribePRODUCT NAME: ACYCLOVIR ET HYDROCORTISONE; NAT. REGISTRATION NO/DATE: NL 36 826 20100420; FIRST REGISTRATION: SK - 2108/08467-R 20091026
C0067France► SubscribePRODUCT NAME: AZELASTINE OU SES SELS PHARMACEUTIQUEMENT ACCEPTABLES ET UN ESTER PHARMACEUTIQUEMENT ACCEPTABLE DE FLUTICASONE; NAT. REGISTRATION NO/DATE: NL41755 20130925; FIRST REGISTRATION: SK - 24/0055/13-S 20130215
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Covington
Cantor Fitzgerald
Daiichi Sankyo
US Department of Justice
Fish and Richardson
QuintilesIMS
Express Scripts
Argus Health
Harvard Business School
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot